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ABSTRACT 
Objectives 
National guidelines advocate referring patients with persistent synovitis to rheumatology 
within 3 working days of presentation to primary care. This infrequently occurs. We aimed to 
identify modifiable barriers to early referral of suspected rheumatoid arthritis (RA) patients 
amongst English GPs. 
 
Methods 
National cross-sectional survey of 1,388 English GPs (RA-QUEST study). Questions 
addressed GPs’ confidence in diagnosing RA, clinical factors influencing RA 
diagnosis/referral, timeliness of referrals, and secondary care access. Data were captured 
using 10-point visual analogue scales (VAS), 5-point Likert scales, yes/no questions, or free-
text, and were analysed descriptively. 
 
Results 
Small joint swelling and pain were most influential in diagnosing RA (91% and 84% rated 
these of 4 or 5 importance on 5-point Likert scale, respectively); investigations including 
rheumatoid factor (RF; 61% rating 4 or 5) and anti-CCP (72% rating 4 or 5) were less 
influential. Patient history had the greatest impact on the decision to refer (92% rating this 4 
or 5 on 5-point Likert scale), with acute phase markers (74% rating 4 or 5) and serology (76% 
rating 4 or 5) less impactful. Despite the importance placed on history and examination, only 
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26% referred suspected RA immediately without investigations; 95% of GPs organising 
further tests opted to test for RF. 
 
Conclusion 
For suspected RA patients to be referred within 3 days of presentation to primary care there 
needs to be a paradigm shift in GPs’ approaches to making referral decisions, with a focus on 
clinical history and examination findings, and not the use of investigations like RF. 
 
Key Words 
Rheumatoid arthritis, referral, primary care, guidelines. 
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INTRODUCTION 
The early diagnosis and prompt treatment of rheumatoid arthritis (RA) by specialists 
improves patient outcomes (1). In England, the National Institute for Health and Care 
Excellence (NICE) Quality Standards for RA recommend that patients with persistent 
synovitis are referred to a rheumatology service within 3 working days of presentation to 
primary care (2). The British Society for Rheumatology (BSR) Healthcare Quality 
Improvement Partnership (HQIP) national audits based on these quality standards highlighted 
the challenges in achieving them (3), with only 17% and 20% of patients referred within 3 
working days, in the first and second audits, respectively. Similar referral delays from 
primary to secondary care exist in other European countries (4) and North America (5). 
 
Several factors contribute to these referral delays. Firstly, the rarity of RA (annual incidence 
15/100,000 adults (3)) means non-specialists lack experience recognising it. Secondly, the 
heterogeneous nature of early RA can make identifying it challenging (6, 7). Thirdly, GPs 
traditionally make diagnoses before referral, using investigations to support their clinical 
opinion; requesting tests in patients with suspected RA will invariably delay the referral 
process. 
 
Variations in national healthcare structures mean factors contributing to referral delays need 
considering on a country-specific basis. Data on factors associated with GP referral delays of 
suspected RA in England are limited, but existing studies suggest referral decisions are 
strongly influenced by test results – chiefly rheumatoid factor (RF) and radiographs – with 
negative/normal tests making referral less likely or timely (8-10). These studies are limited by 
their regional nature (10), small size (8), or focus on a single factor (9). 
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To increase the proportion of RA referrals meeting the NICE quality standard timeline (3 
working days) a range of modifiable barriers to early referral need to be identified, which 
have generalisable impacts across England. The RA Questionnaire for GPs (RA-QUEST) 
study was designed to achieve this. It is a large, prospective survey of 1,388 English GPs’ 
experiences in diagnosing and referring suspected RA patients to secondary care. 
 
METHODS 
National GP Survey 
5,000 English GPs, randomly selected using Binley’s database (National database of GP 
practice contact details) (11), were mailed a questionnaire in 2014, asking 12 questions about 
challenges in diagnosing and referring suspected RA patients, alongside questions about their 
demographics and primary care practice. 
 
Questionnaire Development 
The questionnaire was developed by a focus group of clinical and academic GPs, and 
rheumatologists at Keele University; it was subsequently piloted and refined with local GPs 
prior to national implementation. Question items were sought to cover GP access to 
rheumatology, knowledge of RA symptoms/signs, confidence in diagnosing RA, and which 
factors influence the decision to refer and timescale of referral.  
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Questions About Challenges in Diagnosing and Referring Suspected RA 
The 12 questions about diagnosing and referring patients with suspected RA are provided in 
Supplementary Table 1 and Supplementary Figure 1. In brief, they evaluated GP confidence 
at diagnosing RA and recognising synovitis; how many patients GPs suspected they had seen 
with new-onset RA in the previous 2-years; what GPs felt were the most important symptoms 
in diagnosing RA (with the symptoms listed derived from a previous qualitative study of 
symptom complexes during the earliest phases of RA (7)); if they had heard of the S-factor 
campaign (an Arthritis Research UK/National RA Society delivered campaign promoting the 
need for patients to consult their GP early for symptoms of RA (12)) and its impact on their 
practice; what they felt were the most important features in making a decision to refer a 
patient with suspected RA; whether they referred patients with suspected RA immediately or 
requested further tests first; their access to secondary care rheumatology; and what they felt 
were the challenges in making an RA diagnosis. These were completed using a mixture of: 
(a) 10-point visual analogue scales (VAS) e.g. “how confident are you at diagnosing RA” on 
a scale of 0 (not at all confident) to 10 (completely confident); (b) yes/no responses e.g. “do 
you have access to a dedicated early arthritis clinic?”; (c) 5-point Likert scales; or (4) free-
text boxes. 
 
Statistical analysis 
All data were summarised descriptively, using mean (SD), median (IQR), and number 
(percentage) where appropriate based on data type, and distributions. The associations 
between GP time since qualification and gender, and confidence in diagnosing RA and 
referral practice, were evaluated using linear and logistic regression models. Missing data 
were omitted from the analysis (Supplementary Table 2). 
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Ethical Approval 
The study was approved by the Keele University Ethics Review Panel (ERP1). As it 
represented an anonymous study of primary care practitioners, national ethical committee 
approval was not required. Written informed consent was obtained from participating 
practitioners. 
 
RESULTS 
GP Characteristics 
1,388 completed questionnaires were returned (28% response rate). Most GPs were partners 
(845, 61%), with salaried (291; 21%), senior partner (207; 15%) and locum (36; 3%) GPs 
being less common. Their mean age was 47 years, mean time since qualification was 23 
years, and 705 (51%) were male. Only 38 GPs (3%) had heard of the S-factor campaign. Of 
those completing the free-text response regarding its impact on their clinical practice, the 
commonest responses were that it helped in identifying patients with RA (9 GPs; 24%), 
increased awareness of RA (4 GPs; 11%), meant they were more likely to refer suspected RA 
patients early (3 GPs, 8%), or had no impact (9 GPs, 24%). A bar-plot outlining these 
responses is given in Supplementary Figure 2.  The median score for the number of patients 
with suspected RA seen over the preceding 2 years was 4 (IQR 2-6). 
 
Access to Rheumatology 
498 (38%) GPs had access to dedicated early arthritis clinics. The median VAS rating for 
ease of access to secondary care rheumatology was 7 (IQR 5-8) indicating most GPs 
considered they had moderate ease of access (Figure 1, Panel C). GPs reporting access to 
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dedicated early arthritis clinics had a higher median VAS (7; IQR 6-8) for ease of access to 
rheumatology compared to those reporting no access to early arthritis clinics (6; IQR 5-8). 
 
Challenges in Diagnosing RA 
Key Clinical Features 
Of the 24 clinical features provided, GPs identified the following five as the most important 
in diagnosing RA (Figure 2, Panel A): small joint swelling (91% rated this 4 or 5 for 
importance, out of a possible 5), small joint pain (84% rated this 4 or 5 for importance), 
raised ESR/CRP (82% rated this 4 or 5 for importance), early morning stiffness >60 minutes 
(80% rated this 4 or 5 for importance), and symmetrical joint swelling (78% rated this 4 or 5 
for importance). Median Likert scores were 4 (IQR 4-5) for all five features. 
 
Likert scores for other features included in RA classification criteria (13, 14) were considered 
less diagnostically important: positive anti-CCP (72% rated this 4 or 5 for importance), any 
joint swelling (64% rated this 4 or 5 for importance), positive RF (61% rated this 4 or 5 for 
importance), radiographic changes consistent with RA (57% rated this 4 or 5 for importance). 
Median Likert scores were 4 (IQR 3-5) for anti-CCP and 4 (IQR 3-4) for the other clinical 
features. 
 
Confidence 
GPs were moderately confident at diagnosing RA and detecting synovitis, with median self-
rated VAS of 7 (5-7) and 7 (6-8) out of 10, respectively (Figure 1, Panels A and B). 
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Key Challenges 
The main perceived challenges in diagnosing RA were “the earliest phases of RA are difficult 
to diagnose”, and “RA can be difficult to distinguish from other potential diagnoses”, with 
80% and 82% strongly/moderately agreeing with these statements, respectively (Figure 2, 
Panel B). Despite often requesting RF before making a decision to refer, 48% 
strongly/moderately agreed with the statement “Information provided by RF testing does not 
aid my clinical decisions”. 244 GPs provided free-text information in response to question 12 
(addressing the challenges faced by GPs in diagnosing RA), with the main challenge being a 
perceived delay in access to secondary care services (reported by 98 GPs; 40.2%; 
Supplementary Figure 2).” 
 
Referral Decisions 
Factors Influencing Referrals 
GPs rated patient history as the most important clinical feature in making a decision to refer, 
with 92% rating this 4 or 5 (median score 5; IQR 4-5) out of a possible 5 (Supplementary 
Figure 3). Similar Likert scores were obtained for clinical examination (81% rating 4 or 5; 
median score 4, IQR 4-5), RF/anti-CCP serology (76% rating 4 or 5; median score 4, IQR 4-
5), and raised ESR/CRP (74% rating 4 or 5; median score 4, IQR 3-5). Little weight was 
placed on family history of RA (39% rating 4 or 5; median score 3, IQR 3-4). 78 GPs 
provided free-text information on additional factors they felt important in making a decision 
to refer a patient (Supplementary Figure 2), with the commonest responses being X-rays (14 
GPs; 17.9%), disability (7 GPs; 9%), persistent or severe symptoms (7 GPs; 9%), stiffness (7 
GPs; 9%), and synovitis (7 GPs; 9%). 
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Referral Timeliness 
Only 343 (26%) of GPs would refer suspected RA immediately to secondary care; 999 (74%) 
preferred to organise further tests to inform referral decisions. Of the GPs that would organise 
further tests, the most frequently requested were RF (944 GPs; 95%), CRP (932 GPs, 93%), 
and ESR (883 GPs; 88%). Radiographs (544 GPs; 55%), and anti-CCP antibody testing (433 
GPs; 43%) were less commonly used, and joint ultrasound (32 GPs; 3%) used rarely. 160 
GPs provided free-text information on additional tests they would use (Supplementary Figure 
2), with the commonest being a list of multiple different blood tests (many of which included 
ANA and uric acid; 75 GPs; 46.9%), ANA and other autoantibodies (19 GPs; 11.9%), and 
full blood count tests (17 GPs; 10.6%). 
 
Associations between GP Demographics, Confidence and Referral Practice 
GP Time Since Qualification 
In a linear regression model, which included confidence in diagnosing RA (on a 10-point 
VAS) as the response variable, and time since qualification (in years) as the explanatory 
variable, a significant association was observed (P=0.01), suggesting that GP confidence at 
diagnosing RA increases as more clinical experience is accrued. The effect was, however, 
small with a β-value of 0.01 indicating that per 10-year increase in the time since 
qualification, the confidence in diagnosing RA VAS increased by just 0.10 (out of a possible 
10 units). 
 
In a logistic regression model including the binary answer to the question “if you suspect RA 
clinically do you refer immediately or arrange further tests first?” as the response variable, 
and time since qualification as the explanatory variable no association was seen (P=0.62). 
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GP Gender 
Undertaking the same modelling approach but including GP gender as the explanatory 
variable (in place of time since qualification), an association was observed between gender 
and reported confidence in diagnosing RA (P<0.01) but not referral practice (P=0.49). 
Female GPs appeared to be more confident at diagnosing RA. The β-value of 0.45 obtained 
from the linear regression model indicated that females had a 0.45 higher VAS for confidence 
in diagnosing RA than males. 
 
DISCUSSION 
Our national survey of English GPs found that when they suspect a patient has RA, the 
majority (74%) request investigations to support their clinical opinion before referral. 
Consequently, most GPs cannot meet the NICE quality standard of referring patients with 
persistent synovitis within 3 days. Meeting this quality standard requires a paradigm shift in 
the primary care approach to inflammatory arthritis referrals, with patients presenting with 
synovitis referred on clinical grounds without waiting for the results of investigations. As our 
survey showed that GPs have a good knowledge of the clinical features of RA – with most 
correctly identifying small joint swelling, pain, early morning stiffness and symmetrical joint 
swelling as the most important symptoms/signs – this change in practice should be 
achievable.  
 
We found an over-reliance on RF-testing in primary care, undertaken in 95% of those GPs 
requesting tests before referral. Whilst we did not capture information on whether RF-status 
influences final referral decisions, two previous English studies reported that RF-negative 
patients were less likely to be referred (10), or referred significantly later (9). Another study 
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of 36,191 RF requests made to one English laboratory between 2003-2009 at an annual cost 
of £58,164, found the majority (67%) originated from primary care with only 7% made by 
rheumatologists (15). The rate of positive results in primary care was low at 6%, compared 
with 18% for rheumatologists. When these findings are considered against NICE 
recommendations, there is an argument for restricting the use of RF-testing to rheumatology 
units. 
 
Another major source of delay in suspected RA patients being seen lies with secondary care 
services failing to see primary care referrals promptly. Our study suggests this is an ongoing 
issue, with 62% of GPs reporting no access to early arthritis clinics, and 25% rating their ease 
of access to rheumatology as being ≤5 out of 10. The need to minimise secondary care delay 
is also addressed in the NICE RA Quality Standards, which recommend that people with 
suspected persistent synovitis are assessed in a rheumatology service within 3 weeks of 
referral. The BSR HQIP audit reported that the presence of early inflammatory arthritis 
clinics increased the odds of meeting this standard by 60% (OR 1.6; 95% CI 1.4-1.7; 
P<0.001). This suggests that changes in primary care referral practice need to be linked with 
an increased provision of early inflammatory arthritis clinics. 
 
Our study’s strength is it represents a large national survey with GP practices randomly 
selected. Its limitation is the modest response rate (28%). Our response rate is, however, 
similar to other recent national UK surveys (16, 17), and a low-response rate does not 
necessarily indicate non-response bias (18), with previous research showing similar results in 
early survey responders compared with those responding after intensive contact attempts 
(19). 
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 In conclusion, our findings suggest that to increase the proportion of suspected RA patients 
being referred within 3 days of presentation to primary care, there needs to be a paradigm 
shift in GPs’ approaches to making referral decisions in patients with synovitis, moving away 
from the use of investigations to “confirm” their clinical suspicion of RA, to referring 
patients based on clinical findings.  Further research is required to determine the best manner 
to implement this change in referral practice, and evaluate its impact on attaining NICE 
quality standards. 
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KEY MESSAGES 
• Most GPs organise tests before deciding to refer suspected RA patients. 
• An over-reliance is placed on RF-testing when making referral decisions for suspected 
RA. 
• A change in referral practice is required, making decisions based on clinical findings
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Figure 1 Confidence in Diagnosing RA (Panel A) and Detecting Synovitis (Panel B), and 
Ease of Access to Rheumatology (Panel C). 
 
 
Panel A = GP confidence on Likert Scale (0-10) in diagnosing RA; Panel B = GP confidence 
on Likert Scale (0-10) in recognising synovitis; Panel C = GP rating “How easy is it for you 
to access secondary care rheumatology?” on a visual analogue scale of 0-10. 
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Figure 2. Important Clinical Features (Panel A) and Perceived Challenges (Panel B) in 
Diagnosing RA 
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